VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here : IndiaNotes >> Research & Analysis >> Companies >> Zensar Technologies Ltd. >> Research

Zensar Technologies Q1FY17: Revenue growth exceeds estimates; maintain Buy

Motilal Oswal | 27 Jul, 2016  | Follow Author | Add to my Favourites 
  • Rate this article
    (Average Rating 0.0 Based on 0 ratings)



Revenue beat despite continued consolidation signifies on-track recovery and sustained traction


Revenue growth exceeds estimates…:


Zensar Technologies’ (ZENT)  1QFY17 revenue growth of 2.6% QoQ exceeded our estimate of +1.5% QoQ. Growth was largely led by ramp-up in new deals and continued strength in Digital, which now accounts for 27.3% of total revenue. Apart from Commerce, ZENT strengthened its presence in Digital by launching a suite of products to tap the CMO budget.


despite continued restructuring:


Growth was strong, despite consolidation of low-yield and non-scalable accounts (from 211 to 183 in two quarters) as well as further decline in the Product business (now ~4% of total revenue). Top 6-10 accounts grew by 17.3% QoQ and top 11-20 by 4.7% QoQ, reflecting the fruition of account mining. Momentum in  large deal wins strengthened considerably, with a pipeline of USD200m+ in 1QFY17, compared to USD75m two quarters ago.


Margin expansion capped by onsite-centricity:


Margins expanded only 150bp QoQ to 13.8% (v/s expectation of 350bp), despite the 200bp tailwind from the previous quarter’s one-off provisioning. Higher onsite growth and lower utilization capped the quantum of expansion. However, this situation is likely to improve and hence partly offset wage hike pressure in 2Q.


Continued strategy execution key to re-rating:


We expect 5% revenue growth in FY17 due to consolidation of non-core areas. However, strength in focus areas and execution progress lend confidence of 12% growth in FY18. Despite re-investments, we believe portfolio reconstitution and revenue growth revival should lead to margin expansion of 210bp over the next two years. Given the improved positioning of ZENT, the pace at which it is revamping its business and consequent improvement in financials, we see potential for  growth acceleration and re-rating. We thus maintain our Buy rating with a one-year price target of INR1,300, discounting forward EPS by 13x.

 


  Read full report Click here to read the full report

logo
BSE
780.30 -5.30
(-0.67%)
NSE
783.00 -6.40
(-0.81%)
Read More
About Motilal Oswal

Motilal Oswal was founded in 1987 as a small sub-broking unit, with just two people running the show. Today it has a 2000 member team with a networth of Rs7 bn and market capitalization as of March 31, 2008 at Rs19 bn.

 

For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor IndiaNotes.com accept any liability whatsoever arising from the use of any of the above contents.




Technical Calls

What are technical calls?

Other Articles


Have a question?

CapitalVia
Investment Advisory Company - Financial Market Research and Consulting